Use of pro-drug instead of active [Bioanalytics]

posted by Ionsource – Pakistan, 2012-08-04 15:07 (4684 d 05:48 ago) – Posting: # 9036
Views: 5,361

Hi everybody

Is it appropriate to use Candesartan cilexitil instead of candesartan (unesterified) to develop analytical method for candesartan. I personally believe it shouldn't be done but I got confused when I had read in FDA guidance the following text
"If possible, the reference standard should be identical to the analyte. When this is not possible, an established chemical form (free base or acid, salt or ester) of known purity can be used". how could an ester be used instead?

Please somebody let me know. thanks

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
30 visitors (0 registered, 30 guests [including 12 identified bots]).
Forum time: 20:56 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5